CME Office: 
Series date: 
Thursday, January 9, 2020 - 12:30pm to Thursday, November 19, 2020 - 1:30pm

Content:

Multiple specialists are involved with the care of oncology patients. Optimal  care of patients with malignancy requires input from surgery, oncology, pathology and other specialists. Not all physicians are aware of the latest developments in specialties that are outside of their primary area of expertise. Multidisciplinary individualized optimized treatment planning for all patients diagnosed with cancer at our medical center.


Target Audience: Internal Medicine (like Gastroenterology, Medical Oncologists/Hematology, Pulmonology), Pathology, Radiology, Radiation Oncology, Surgery and other specialists involved in the care of oncology patients.


Learning Objectives: Upon completion of this activity, participants should be able to:

  1. Identify and use the best treatment pathway for relevant cancer patients through a multi-disciplinary team approach.
  2. Implement recommendations from case presentations to improve evaluation, diagnosis, and treatment of cancer.

Planning Committee:

  • William Huang, MD, Department of Medical Oncology/Hematology
  • Shreya Shah,MD, Department of Medical Oncology/Hematology
  • Jie Zheng, MD, Chief of Medical Education
  • Tenisha Jones, MLIS, Assistant Medical Librarian
  • Agnes Lau, Sr. Quality Specialist

Cultural and Linguistic Competency:

Patients with language barriers have difficulty understanding complex cancer treatment plans, leading to miscommunications or non-compliance with treatment. Through Tumor Board, we will encourage the use of in-person or video interpreters when we see patients in-clinic.


References:

  • Peer literature review via Kaiser Clinical library - https://clm.kp.org/wps/portal/cl/NCAL?
  • National Comprehensive Cancer Network Guideline - www.nccn.org
  • American Society of Clinical Oncology Guidelines - www.asco.org
  • American Society of Hematology Guidelines - www.hematology.org/Clinicians/Guidelines-Quality/
  • New England Journal of Medicine - www.nejm.org/
  • KP Oncology Clinical Trials Program -  https://healthy.kaiserpermanente.org/health/care/!ut/p/a0/FchRDoIwDADQs3CApiIMqH9LLFfQ7a9pFlzCClkWvb76-R5GfGI0eedNWj5M9p-DJmup3lRMU8UHRoxnla0IBjtARV_pf1Jb1j1hGHld58FNQINn6Hu-AJEnoNG5-zLTdWLGs5Tl47vuC0F5nVc!/
  • NCI Community Oncology Research Program - ncorp.cancer.gov/
  • UptoDate - http://www.uptodate.com/home
  • Review specific articles based on cases as they develop 

Disclosure Statement:

The regular presenters and program planners of this case conference have disclosed that they have no relevant financial relationships with commercial interest (s). The CME Department has reviewed their disclosure information for the planner(s) and/or committee / faculty or this program and they do not have relationships that present a relevant financial conflict of interest.

Kaiser Permanente South San Francisco takes responsibility for the content, quality, and scientific integrity of this CME Activity.

Kaiser Permanente does not endorse any brand-name products.

Accreditation Statement:

Kaiser Permanente South San Francisco Medical Center is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.

Credit Statement:

The Kaiser Permanente South San Francisco Medical Center designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses may report up to a maximum total of 1.0 AMA PRA Category 1 Credit(s)™ towards the Continuing Medical Education requirements for license renewal by the California Board of Registered Nurses.

Other credit have been planned on a session by session basis, by this planning committee in the categories of Radiologic Technology (1.0 per session).

Series location: 
Kaiser Permanente
1200 El Camino Real
MS Teams
South San Francisco, CA 94080
United States